Concepedia

Pamela W. Anderson

PW

27

Publications

2.8K

Citations

22

H-Index

1989

Active since

Affiliations

Eli Lilly (United States)(Current)

University of Southern California

Los Angeles Medical Center

University of California San Diego

LAC+USC Medical Center

Pamela W. Anderson is an author at Eli Lilly (United States) specializing in medicine, cardiovascular disease, and pharmacotherapy.

Top concepts

Publications per year

1989–2016

27

Publications

27

Raloxifene and Cardiovascular Events in Osteoporotic Postmenopausal Women

Elizabeth Barrett‐Connor, Deborah Grady, Andreas Sashegyi et al. · JAMA · 2002 · 574 citations

The Effects of Hormone Replacement Therapy and Raloxifene on C-Reactive Protein and Homocysteine in Healthy Postmenopausal Women: A Randomized, Controlled Trial1

Brian W. Walsh, Sofia Paul, Robert A. Wild et al. · The Journal of Clinical Endocrinology & Metabolism · 2000 · 331 citations · Full text

, , +16

The Effect of Ruboxistaurin on Nephropathy in Type 2 Diabetes

Katherine R. Tuttle, George L. Bakris, Robert D. Toto et al. · Diabetes Care · 2005 · 301 citations · Full text

Efficacy and safety of subcutaneous tabalumab, a monoclonal antibody to B-cell activating factor, in patients with systemic lupus erythematosus: results from ILLUMINATE-2, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study

Joan T. Merrill, Ronald van Vollenhoven, Jill P. Buyon et al. · Annals of the Rheumatic Diseases · 2015 · 218 citations · Full text

Design and methods of the Raloxifene Use for The Heart (RUTH) study

Lori Mosca, Elizabeth Barrett‐Connor, Nanette K. Wenger et al. · The American Journal of Cardiology · 2001 · 166 citations

, , +7

Rows per page

1–5 of 27